Avatrel® 30 Capsules used for:

In the general population and particularly in people with intestinal disorders.

Avatrel® 30 Capsules:

Oxidative stress is intimately linked to intestinal disorders, high ROS production and decreased antioxidant enzymes in the intestinal mucosa is often one of the causes of numerous intestinal disorders.

The turmeric rhizome contains a number of substances called curcuminoids, of which curcumin is the most important. Turmeric can help control oxidative stress and contributes to intestinal comfort. The main difficulty of the components of turmeric is absorption by the body. The bioactive turmeric extract (Theracurmin®), included in Avatrel®, is obtained through a specific formulation process, which improves its bioavailability to obtain its maximum benefits.

The “boswellic acids”, which we extract from boswellia serrata, help us to maintain the health of the digestive tract and to calm the intestine, in addition to helping to maintain the lining of the walls of the digestive system. The most important is boswellic acid – AKBA, a component of Avatrel® which we have enriched more than 5 times through a specific formulation (Akbamax®).

Hydroxytyrosol is a phenolic compound derived from the extract of Olea Europaea L., which helps to protect the lipids of the blood plasma against oxidative stress, in order to help maintain the normal functioning of the gastrointestinal tract.

Presentación Cognex



Avatrel® by Laboratorios Farmolab is a food supplement that can provide an intestinal protective effect.

It is believed that pathologies associated with inflammatory bowel disease, both inflammation and continued and excessive activation of the intestinal mucosa by the immune system, are related to an aberrant response caused by defects both in the intestinal epithelium barrier and in the immune system of the mucosa.

In such situations, being able to offer protection against uncontrolled inflammation, for instance controlling excessive oxidative stress, can be of great help.


NATIONAL CODE (C.N.): 197023.7
Box of 30 capsules.

Instructions for use:

It is recommended to take 1-2 capsules per day.

A minimum of 6 months is recommended. Avatrel® can be taken on an ongoing long-term basis.

It is suitable for gluten- and lactose-intolerant patients and diabetics.

Store in a cool and dry place, away from light, at a temperature less than 25° C. Avoid sudden changes in temperature. The expiration date is applicable to the product with the original packaging intact and properly stored. Keep out of reach of children under 3 years of age. Food supplements are not intended to replace a varied and balanced diet and a healthy lifestyle. Do not exceed the suggested daily dose. Do not take in case of hypersensitivity to one or more components of this product.


Theracurmin® – 30mg

Is a Submicron Colloidal  Dispersion Particles of Curcuminoids and Curcuminoids, about the size of the nanoscale, that are stable and dispersible in water. This new curcumin formulation stimulates its absorption and bioavailability. Curcumin is an antioxidant polyphenol that can help control oxidative stress and contributes to intestinal comfort.

Hydroxytyrosol – 5mg

Phenolic compound obtained from Olea Europea L extract, which helps to protect the lipids of the blood plasma against oxidative stress, in order to help maintain the normal functioning of the gastrointestinal tract.

Akbamax® – 100mg

Contains boswellic acids from Boswellia Serrata, that can favour the digestive tract health and calm the intestines, as well as help maintain the lining of the digestive system.


Podolsky, D. K. (2002). Inflammatory Bowel Disease. New England Journal of Medicine, 347(6), 417–429.Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuñoa MI. Benefits of polyphenols on gut microbiota and implications in human health. Journal of Nutritional Biochemistry 24 (2013) 1415-1422. Sheehan D, Moran C, Shanahan F. The microbiota in inflammatory bowel disease. J Gastroenterol (2015) 50:495–507. Lang A., Salomon N., Wu J. C. Y., Kopylov U., Lahat A., Har-Noy O., Ching J. Y. L., Cheong P., Avidan B., ,Gamus D., Kaimakliotis I., Eliakim K. R., Ng C. S., Ben-Horin, S. (2015). Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 13(8), 1444–1449.e1. Mizumoto A., Ohashi S., Kamada M., Saito T., Nakai Y., Baba K., Hirohashi K., Mitani Y., Kikuchi O., Matsubara J., Yamada A., Takahashi T., Lee H., Okuno Y., Kanai M., Muto M., (2019). Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma. Journal of Gastroenterology. Sugimoto, Ken and Ikeya, Kentaro and Bamba, Shigeki and Andoh, Akira and Yamasaki, Hiroshi and Mitsuyama, Keiichi and Nasuno, Masanao and Tanaka, Hiroki and Matsuura, Ai and Kato, Masaichi and Ishida, Natsuki and Tamura, Satoshi and Takano, Ryosuke and Tani, Shinya and Osawa, Satoshi and Nishihira, Jun and Hanai, Hiroyuki, Highly Bioavailable Curcumin Derivative ‘Theracurmin®’ for Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Multicentre Study (09/22/2019 05:15:36). Available at SSRN: https://ssrn.com/abstract=3458509 or http://dx.doi.org/10.2139/ssrn.3458509. Ohno M, Nishida A, Sugitani Y, Nishino K, Inatomi O, Sugimoto M, et al. (2017) Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS ONE 12(10): e0185999. Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull., 34, 660–665 (2011). 23). Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamoto M, Okamura N, Hojo Y, Suzuki H, Doi O, Yokoji T, Morimoto E, Takahashi T, Ozawa H, Imaizumi A, Ueno M, Kakeya H, Shimatsu A, Wada H, Hasegawa K, Morimoto T. Colloidal submicron-particle curcumin exhibits high absorption efficiency—a double-blind, 3-way crossover study. J. Nutr. Sci. Vitaminol., 61, 37–44 (2015). Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother. Pharmacol., 71, 1521–1530 (2013). Takahashi M, Suzuki K, Kim HK, Otsuka Y, Imaizumi A, Miyashita M, Sakamoto S. Effects of curcumin supplementation on exercise-induced oxidative stress in humans. Int. J. Sports Med., 35, 469–475 (2014). Imaizumi A. Highly bioavailable curcumin (Theracurmin): its development and clinical application. PharmaNutrition, 3, 123–130 (2015). Pontoniere P, Martiradonna D. Inflammation and olive polyphenols. A perspective review of supporting literature. Agro Food Ind Hi Tec. 2012;23:69–71. Voltes, A., Bermúdez, A., Rodríguez-Gutiérrez, G., Reyes, M. L., Olano, C., Fernández-Bolaños, J., & Portilla, F. de la. (2018). Anti-Inflammatory Local Effect of Hydroxytyrosol Combined with Pectin-Alginate and Olive Oil on Trinitrobenzene Sulfonic Acid-Induced Colitis inWistar Rats. Journal of Investigative Surgery, 1–7. Larussa, T., Oliverio, M., Suraci, E., Greco, M., Placida, R., Gervasi, S., Marasco R., Imeneo M., Paolino D., Tucci L., Gulletta E., Fresta M., Procopio A. and Luzza F., (2017). Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients. Nutrients, 9(4), 391. Terzuoli, E., Giachetti, A., Ziche, M., & Donnini, S. (2015). Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation. Molecular Nutrition & Food Research, 60(3), 519–529. Gupta I, Parihar A, Malhotra P, Singh GB, Lüdtke R, Safayhi H, Ammon HP. Effects of Gum Resin of Boswellia serrata in Patients with Chronic Colitis. Eur J Med Res. 1997 Jan;2(1):37-43. Parian, A. M., Limketkai, B. N., Shah, N. D., & Mullin, G. E. (2015). Nutraceutical Supplements for Inflammatory Bowel Disease. Nutrition in Clinical Practice, 30(4), 551–558. Holleran, G., Scaldaferri, F., Gasbarrini, A., & Currò, D. (2019). Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials. Phytotherapy Research.